These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15380143)

  • 21. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
    Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obesity and the polycystic ovary syndrome.
    Martínez-Bermejo E; Luque-Ramírez M; Escobar-Morreale HF
    Minerva Endocrinol; 2007 Sep; 32(3):129-40. PubMed ID: 17912153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic and hormonal aspects of polycystic ovary syndrome: the impact of diet.
    O'Connor A; Gibney J; Roche HM
    Proc Nutr Soc; 2010 Nov; 69(4):628-35. PubMed ID: 20696094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.
    Nardo LG; Patchava S; Laing I
    Panminerva Med; 2008 Dec; 50(4):267-78. PubMed ID: 19078868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin resistance in patients with polycystic ovary syndrome.
    Schröder AK; Tauchert S; Ortmann O; Diedrich K; Weiss JM
    Ann Med; 2004; 36(6):426-39. PubMed ID: 15513294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian function and obesity--interrelationship, impact on women's reproductive lifespan and treatment options.
    Rachoń D; Teede H
    Mol Cell Endocrinol; 2010 Mar; 316(2):172-9. PubMed ID: 19818376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term weight maintenance and cardiovascular risk factors are not different following weight loss on carbohydrate-restricted diets high in either monounsaturated fat or protein in obese hyperinsulinaemic men and women.
    Keogh JB; Luscombe-Marsh ND; Noakes M; Wittert GA; Clifton PM
    Br J Nutr; 2007 Feb; 97(2):405-10. PubMed ID: 17298712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
    Thomann R; Rossinelli N; Keller U; Tirri BF; De Geyter C; Ruiz J; Kränzlin M; Puder JJ
    Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin resistance and polycystic ovary syndrome.
    Galluzzo A; Amato MC; Giordano C
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):511-8. PubMed ID: 18657405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polycystic ovary syndrome in the adolescent.
    Pfeifer SM; Kives S
    Obstet Gynecol Clin North Am; 2009 Mar; 36(1):129-52. PubMed ID: 19344852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study.
    Palomba S; Giallauria F; Falbo A; Russo T; Oppedisano R; Tolino A; Colao A; Vigorito C; Zullo F; Orio F
    Hum Reprod; 2008 Mar; 23(3):642-50. PubMed ID: 18158291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular health in women with polycystic ovary syndrome.
    Sukalich S; Guzick D
    Semin Reprod Med; 2003 Aug; 21(3):309-15. PubMed ID: 14593554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long-term risks of polycystic ovaries syndrome].
    Lefebvre P; Raingeard I; Renard E; Bringer J
    Gynecol Obstet Fertil; 2004 Mar; 32(3):193-8. PubMed ID: 15123116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin resistance syndrome and polycystic ovary syndrome: implications for diagnosis and treatment.
    Tan S; Hahn S; Janssen OE
    Panminerva Med; 2005 Dec; 47(4):211-7. PubMed ID: 16489320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term effects of popular dietary approaches on weight loss and features of insulin resistance.
    McAuley KA; Smith KJ; Taylor RW; McLay RT; Williams SM; Mann JI
    Int J Obes (Lond); 2006 Feb; 30(2):342-9. PubMed ID: 16158081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acupuncture in polycystic ovary syndrome: current experimental and clinical evidence.
    Stener-Victorin E; Jedel E; Mannerås L
    J Neuroendocrinol; 2008 Mar; 20(3):290-8. PubMed ID: 18047551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.
    Tang T; Glanville J; Hayden CJ; White D; Barth JH; Balen AH
    Hum Reprod; 2006 Jan; 21(1):80-9. PubMed ID: 16199429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The management of insulin resistance in polycystic ovary syndrome.
    Teede HJ; Hutchison SK; Zoungas S
    Trends Endocrinol Metab; 2007 Sep; 18(7):273-9. PubMed ID: 17698366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.
    Glueck CJ; Morrison JA; Friedman LA; Goldenberg N; Stroop DM; Wang P
    Metabolism; 2006 Apr; 55(4):508-14. PubMed ID: 16546482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.